rhenium-186 hedp has been researched along with gemcitabine in 1 studies
Studies (rhenium-186 hedp) | Trials (rhenium-186 hedp) | Recent Studies (post-2010) (rhenium-186 hedp) | Studies (gemcitabine) | Trials (gemcitabine) | Recent Studies (post-2010) (gemcitabine) |
---|---|---|---|---|---|
75 | 32 | 19 | 12,523 | 3,208 | 6,923 |
Protein | Taxonomy | rhenium-186 hedp (IC50) | gemcitabine (IC50) |
---|---|---|---|
Chain A, DEOXYNUCLEOSIDE KINASE | Drosophila melanogaster (fruit fly) | 0.76 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 0.19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Mabhouh, AA; Mercer, JR | 1 |
1 other study(ies) available for rhenium-186 hedp and gemcitabine
Article | Year |
---|---|
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |